$PAHC News

PAHC or LZAGY: Which Is the Better Value Stock Right Now?

Phibro Animal Health (PAHC) Leaves Russell Indexes, Is The Stock A Bargain?

Phibro Animal Health (PAHC) Stock Looks Reasonable On Value But Stretched After 138% Gain

Phibro Animal Health (PAHC) Stock Loses Russell Index Spots And Investor Visibility

Implied Volatility Surging for Phibro Animal Health Stock Options

Q1 Rundown: Phibro Animal Health (NASDAQ:PAHC) Vs Other Branded Pharmaceuticals Stocks

Wall Street Analysts Predict a 36.23% Upside in Phibro (PAHC): Here's What You Should Know

Phibro Animal Health Appoints Daniel (Dani) Bendheim As CEO And President Effective July 1, 2026

Phibro Animal Health Corporation: Stable But Limited Near-Term Upside

What Makes Phibro (PAHC) a New Buy Stock

Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

Citigroup Maintains Neutral on Phibro Animal Health, Lowers Price Target to $44

Phibro Animal Health Corporation (PAHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Phibro Animal Health Corporation 2026 Q3 - Results - Earnings Call Presentation

Phibro Animal Health Corporation (PAHC) Q3 2026 Earnings Call Transcript

Phibro Animal Health (NASDAQ:PAHC) Beats Q3 Estimates, But Stock Slides on Brazil Regulatory Uncertainty

Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.93-$3.10 to $2.98-$3.10 vs $3.03 Est; Raises FY2026 Sales Guidance from $1.45B-$1.50B to $1.46B-$1.50B vs $1.488B Est

Phibro Animal Health Corporation Announces Expected Implementation Of New Regulatory Framework Governing The Use Of Certain Antimicrobials In Brazil

Citigroup Initiates Coverage On Phibro Animal Health with Neutral Rating, Announces Price Target of $62